Clinical Trial Update: Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of pitavastatin in combination with PCSK9 inhibitors in liver transplant patients with dyslipid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia

Drugs mentioned

• PCSK9 inhibitors
• Pitavastatin (Pitavastatin)

Snippet

Sponsor: National Medical Research Center for Therapy and Preventive Medicine | Conditions: Dyslipidemias, Hyperlipidemias | Phase 4 | Status: ACTIVE_NOT_RECRUITING